CBD oil shows promise for easing anxiety and depression in Parkinson's patients

NCT ID NCT07651930

Completed Symptom relief Sponsor: Medical University of Warsaw Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested whether full-spectrum CBD oil can help with anxiety and depression in people with Parkinson's disease. Twenty-seven participants took one of three daily doses (30, 60, or 300 mg) for two months. Researchers measured changes in anxiety and depression scores, along with sleep, fatigue, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: full-spectrum cannabidiol (CBD) oil
What this could lead to: If it works, this could point toward a safe, natural supplement to ease anxiety and depression in people with Parkinson's disease.
What could go wrong: This is a small, early-phase trial with only 27 participants. The results may not apply to everyone, and CBD can cause side effects like drowsiness or stomach issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE (PD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder Depression Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON'S DISEASE (PD)

Contacts and locations

Locations

Department of Neurology, Faculty of Health Sciences, Medical University of Warsaw

Warsaw, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.